15 minutes
In an extremely complex and rapidly changing treatment landscape, patients with multiple myeloma have a growing opportunity to have a voice in their own care. However, patients need foundational education about their disease in order to feel empowered to engage in care decisions. At Takeda, we implemented a community-based Patient Advocacy Liaison program that delivers impactful disease education with a focus on patient empowerment, and gathers deeper, unfiltered insights and a better understanding of the needs within the multiple myeloma patient community. This first-in-class program reflects Takeda’s commitment to making decisions based on what’s best for the patient communities we serve.
